Detalhe da pesquisa
1.
The emerging emetogenicity of trifluridine/tipiracil (TAS102) from patient self-reporting: a multicenter, prospective, observational study.
Support Care Cancer
; 32(5): 291, 2024 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38630197
2.
Detection of factors related to treatment reduction in docetaxel and ramucirumab for non-small cell lung cancer treatment.
Sci Rep
; 13(1): 19457, 2023 11 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37945672
3.
Risk factor analysis for cisplatin-induced nephrotoxicity with the short hydration method in diabetic patients.
Sci Rep
; 13(1): 17126, 2023 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37816823
4.
Registry study of immune-related adverse events using electronic patient-reported outcome in patients with cancer receiving immune checkpoint inhibitors: protocol for a multicentre cohort study.
BMJ Open
; 13(11): e073724, 2023 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37993166
5.
Effect of macrophage migration inhibitory factor (MIF) on acute graft-versus-host disease in a murine model of allogeneic stem cell transplantation.
Transpl Immunol
; 16(2): 117-24, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16860715
6.
The immunosuppressive agent FK506 enhances the cytolytic activity of inhibitory natural killer cell receptor (CD94/NKG2A)-expressing CD8 T cells.
Transplantation
; 80(12): 1813-5, 2005 Dec 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-16378079